Replies to post #213528 on Biotech Values

[north40000]

I assume that no final order or judgment has been entered in that E.D. Texas case, and no subsequent appeal has been filed in Fed. Cir. by a losing party in that case.

That court may want to revisit en banc its earlier Covidian et al judgments.

SCOTUS eventual involvement seems inevitable also.

If I was still a member of PTAB, I would vote to suspend further IPR action in AGN case, pending above judicial review.